Project 500 CHILD Study
1 other identifier
observational
500
0 countries
N/A
Brief Summary
This proposal relates to the testing of several specific hypotheses in a subset of 500 participants in the Canadian Healthy Infant Longitudinal Development (CHILD) Study. These 500 now have complete data from the time of recruitment (in pregnancy) to age 1 year. The primary purpose of this proposal is to identify risk factors for early allergic outcomes and biomarkers that may predict future disease. These 500 infants will provide critical preliminary data, not only related to early outcomes, but also to inform analytical plans for the full CHILD cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2008
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2012
CompletedFirst Submitted
Initial submission to the registry
July 7, 2017
CompletedFirst Posted
Study publicly available on registry
July 21, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2018
CompletedSeptember 25, 2017
September 1, 2017
4.2 years
July 7, 2017
September 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Allergic sensitization at 1 year
Skin prick tests to food and inhalant allergies
March 2018
Secondary Outcomes (2)
Early childhood wheeze
Birth to one year
Atopic Dermatitis
Birth to one year
Other Outcomes (1)
Food Allergy
Birth to one year
Eligibility Criteria
The 500 children in Project 500 will be representative of our full cohort. Study members have been recruited from a general population (i.e., not high-risk for asthma and allergy as are many cohorts) from recruitment bases in Vancouver, Edmonton, Winnipeg (including a rural site in Manitoba) and Toronto.
You may qualify if:
- Pregnant women aged 18 years and older (19 in Vancouver) 2. Residence in reasonable proximity to the delivery hospital 3. Able to read, write, and speak English 4. Willing to provide informed consent 5. Willing to consent to cord blood collection for the study 6. Planning to give birth at a designated recruitment centre participating hospital 7. Infants born at or after 35 weeks 8. Able to provide address and telephone number and names and telephone numbers of two alternate contact individuals
You may not qualify if:
- Children with major congenital abnormalities or respiratory distress syndrome (RDS)
- Expectation of moving away from a recruitment area within year 1
- Children of multiple births
- Children resulting from in vitro fertilization
- Children who will not spend at least 80% of nights in the index home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Allergy, Genes and Environment Network (AllerGen) NCEcollaborator
- Canadian Institutes of Health Research (CIHR)collaborator
- St. Joseph's Healthcare Hamiltoncollaborator
- University of Torontocollaborator
- University of Manitobacollaborator
- University of Albertacollaborator
- University of British Columbiacollaborator
Related Publications (4)
Takaro TK, Scott JA, Allen RW, Anand SS, Becker AB, Befus AD, Brauer M, Duncan J, Lefebvre DL, Lou W, Mandhane PJ, McLean KE, Miller G, Sbihi H, Shu H, Subbarao P, Turvey SE, Wheeler AJ, Zeng L, Sears MR, Brook JR; CHILD study investigators. The Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study: assessment of environmental exposures. J Expo Sci Environ Epidemiol. 2015 Nov-Dec;25(6):580-92. doi: 10.1038/jes.2015.7. Epub 2015 Mar 25.
PMID: 25805254BACKGROUNDMoraes TJ, Lefebvre DL, Chooniedass R, Becker AB, Brook JR, Denburg J, HayGlass KT, Hegele RG, Kollmann TR, Macri J, Mandhane PJ, Scott JA, Subbarao P, Takaro TK, Turvey SE, Duncan JD, Sears MR, Befus AD; CHILD Study Investigators. The Canadian healthy infant longitudinal development birth cohort study: biological samples and biobanking. Paediatr Perinat Epidemiol. 2015 Jan;29(1):84-92. doi: 10.1111/ppe.12161. Epub 2014 Nov 18.
PMID: 25405552BACKGROUNDSubbarao P, Anand SS, Becker AB, Befus AD, Brauer M, Brook JR, Denburg JA, HayGlass KT, Kobor MS, Kollmann TR, Kozyrskyj AL, Lou WY, Mandhane PJ, Miller GE, Moraes TJ, Pare PD, Scott JA, Takaro TK, Turvey SE, Duncan JM, Lefebvre DL, Sears MR; CHILD Study investigators. The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma. Thorax. 2015 Oct;70(10):998-1000. doi: 10.1136/thoraxjnl-2015-207246. Epub 2015 Jun 11.
PMID: 26069286BACKGROUNDAzad MB, Robertson B, Atakora F, Becker AB, Subbarao P, Moraes TJ, Mandhane PJ, Turvey SE, Lefebvre DL, Sears MR, Bode L. Human Milk Oligosaccharide Concentrations Are Associated with Multiple Fixed and Modifiable Maternal Characteristics, Environmental Factors, and Feeding Practices. J Nutr. 2018 Nov 1;148(11):1733-1742. doi: 10.1093/jn/nxy175.
PMID: 30247646DERIVED
Related Links
Biospecimen
Cord blood. Child 1 year blood Child 5 year blood. Parental venous blood. Saliva samples. Urine samples. Stool samples. Breast milk samples. Nasal swabs.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Padmaja Subbarao, MD
University of Toronto
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
July 7, 2017
First Posted
July 21, 2017
Study Start
August 31, 2008
Primary Completion
October 31, 2012
Study Completion
March 31, 2018
Last Updated
September 25, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share